NCT06064903View on ClinicalTrials.gov

CD7-CAR-T Cells in Pediatric Relapsed/Refractory CD7+ T-ALL/LL

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

April 21, 2024

Primary Completion Date

September 30, 2028

Study Completion Date

September 30, 2040

Conditions
T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
Interventions
BIOLOGICAL

CD7-CART01

A single IV infusion of CD7-CART01 on Day 0

Trial Locations (1)

00165

RECRUITING

Ospedale Pediatrico Bambino Gesù, Rome

All Listed Sponsors
lead

Bambino Gesù Hospital and Research Institute

OTHER